Investing in Health Care: 3 Innovative New Drugs to Watch
Posted in Investments by Kevin | Tags: biotechnology, cancer, drug, drugs, health care, Investments, malarial drug, nanotechnology, novartis, pharmaceuticalsAccording to analysts, about 1 in 13 successful drugs is a “blockbuster.” Blockbuster drugs net over a billion in revenue and keep pharmaceutical companies profitable. Many new drugs can fail, get out-competed by other drugs, or never hit full stride, costing companies hundreds of millions of dollars lost to research, marketing, and approval.
Recently, I came across a few up and coming drugs and wanted to shed some light on whether investing in their respective manufacturing companies is a good idea or not.
1) Novartis- Malarial Drug – “spiroindolones”
Subscribe for E-mail Updates
Navigate
New on SmarterSpend
- How Hire a Contractor for Less Without Sacrificing Quality
- Top 5 Craigslist Scams to Avoid
- 8 Companies Facing Bankruptcy in 2011
- The Ultimate Personal Finance Blog Rankings from MoneyCrashers!
- Investing in Health Care: 3 Innovative New Drugs to Watch
Hot Topix
free
food
automobile
real estate
discounts
Restaraunts
fast food
save money
Electronics
credit card
house
shopping
world
Utilities
loans
department store
money
save
business
promotions
Physician Assistants
2010
Investments
Cable
companies
Groceries
car
energy
online
Education
wealth
Careers
Spending
el pollo loco
sales
Insurance
Living Expenses
career
Finance
student
dining
lifestyle
jobs
Biomedical Engineers
sale
budget
Clothing
Veterinarians
country
department stores
cheap
camera
Dates
Personal Finance
bill
Electricity
Economy
future
stocks
coupons
Dental Hygienist
gold
household
home
college
invest
World Affairs
Corporate
credit
Health